# IER2

## Relevance tier by entity

|Entity|Tier|Description                              |
|:------:|:----:|-----------------------------------------|
|DLBCL |2   |relevance in DLBCL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source        |frequency (%)|
|:------:|:--------------:|:-------------:|
|DLBCL |GAMBL genomes |0.38         |
|DLBCL |Schmitz cohort|1.91         |
|DLBCL |Reddy cohort  |0.60         |
|DLBCL |Chapuy cohort |1.28         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |2.695           |0               |
|DLBCL |No  |No                   |0.319           |0               |
|FL    |No  |No                   |0.000           |0               |


> [!NOTE]
> First described in DLBCL in 2013 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/23699601)
## IER2 Expression
![image](images/gene_expression/IER2_by_pathology.svg)
<!-- ORIGIN: morinMutationalStructuralAnalysis2013 -->
